U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H27N5O6
Molecular Weight 373.4048
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EA-230

SMILES

CC(C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N)C(O)=O

InChI

InChIKey=DXRXYJYFADHAPA-AUTRQRHGSA-N
InChI=1S/C15H27N5O6/c1-7(2)12(15(25)26)20-11(22)6-18-14(24)9(4-5-10(17)21)19-13(23)8(3)16/h7-9,12H,4-6,16H2,1-3H3,(H2,17,21)(H,18,24)(H,19,23)(H,20,22)(H,25,26)/t8-,9-,12-/m0/s1

HIDE SMILES / InChI

Molecular Formula C15H27N5O6
Molecular Weight 373.4048
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:29:49 GMT 2023
Edited
by admin
on Sat Dec 16 11:29:49 GMT 2023
Record UNII
EJB8KD4JLL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EA-230
Common Name English
AQGV
Common Name English
L-VALINE, L-ALANYL-L-GLUTAMINYLGLYCYL-
Systematic Name English
NMPF-46
Common Name English
(2S)-2-((2-(((2S)-5-AMINO-2-(((2S)-2-AMINOPROPANOYL)AMINO)-5-OXO-PENTANOYL)AMINO)ACETYL)AMINO)-3-METHYL-BUTANOIC ACID
Systematic Name English
Code System Code Type Description
CAS
503844-09-5
Created by admin on Sat Dec 16 11:29:49 GMT 2023 , Edited by admin on Sat Dec 16 11:29:49 GMT 2023
PRIMARY
EPA CompTox
DTXSID80436085
Created by admin on Sat Dec 16 11:29:49 GMT 2023 , Edited by admin on Sat Dec 16 11:29:49 GMT 2023
PRIMARY
PUBCHEM
10133920
Created by admin on Sat Dec 16 11:29:49 GMT 2023 , Edited by admin on Sat Dec 16 11:29:49 GMT 2023
PRIMARY
SMS_ID
300000042358
Created by admin on Sat Dec 16 11:29:49 GMT 2023 , Edited by admin on Sat Dec 16 11:29:49 GMT 2023
PRIMARY
FDA UNII
EJB8KD4JLL
Created by admin on Sat Dec 16 11:29:49 GMT 2023 , Edited by admin on Sat Dec 16 11:29:49 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Class: Anti-inflammatories, Antiseptic, Peptide; Mechanism of Action: Immunomodulator; Highest Development Phase: Phase II Renal failure; Most Recent Event: 07 Oct 2014 Exponential Biotherapies initiates enrolment in a phase I trial for Renal failure (Prevention, In volunteers) in Netherlands (EudraCT2014-002481-78)